Bioventus Inc. (BVS)
USD 10.61
(-4.84%)
USD 10.61
(-4.84%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 15.34 Million | -13.53 Million | 22.99 Million | 71.79 Million | 40.71 Million | 45.18 Million |
| Net Income | -96.73 Million | -213.39 Million | 9.58 Million | 14.72 Million | 8.11 Million | 4.44 Million |
| Depreciation & Amortization | 57.36 Million | 66.8 Million | 34.87 Million | 28.64 Million | 30.31 Million | 29.23 Million |
| Deferred income taxes | -2.37 Million | -52.79 Million | -9.75 Million | -511 Thousand | -348 Thousand | -79 Thousand |
| Stock-based compensation | 2.72 Million | 17.58 Million | 19.84 Million | 10.1 Million | 10.84 Million | 14.32 Million |
| Change in working capital | -3.18 Million | -14.53 Million | -13.27 Million | 15.3 Million | -13.57 Million | 2.85 Million |
| Other non-cash items | 57.55 Million | 182.79 Million | 6.07 Million | 3.53 Million | 5.36 Million | -5.59 Million |
| Investing Cash Flow | 15.8 Million | -116.43 Million | -283.76 Million | -20.5 Million | -7.91 Million | -6.1 Million |
| Investments in PPE | -7.36 Million | -11.52 Million | -7.37 Million | -20.67 Million | -8.34 Million | -6.06 Million |
| Acquisitions | 34.67 Million | -104.84 Million | -262.87 Million | - | 430 Thousand | - |
| Investment purchases | - | - | -13.52 Million | - | - | - |
| Sales/Maturities of investments | - | - | 276.39 Million | - | 430 Thousand | - |
| Other Investing Activities | -11.5 Million | -75 Thousand | -276.39 Million | 172 Thousand | 430 Thousand | -40 Thousand |
| Financing Cash Flow | -26.65 Million | 62.07 Million | 273.37 Million | -29.56 Million | -10.95 Million | -13.25 Million |
| Debt repayment | -26.92 Million | -45.03 Million | -166.2 Million | -59 Million | -199.58 Million | -5.25 Million |
| Dividends payments | - | - | -367 Thousand | -19.88 Million | -9.13 Million | -7.84 Million |
| Common Stock Repurchased | - | -3.35 Million | - | - | - | - |
| Common Stock Issuance | 778 Thousand | 5.82 Million | 107.57 Million | - | - | - |
| Other Financing Activities | -506 Thousand | 107.99 Million | -37 Thousand | 49.31 Million | 197.76 Million | -160 Thousand |
| Accounts receivables | 10.05 Million | -18.02 Million | -20.05 Million | -3.94 Million | -14.9 Million | -12.13 Million |
| Accounts payables | -5.27 Million | 10.91 Thousand | 18.21 Million | 20.51 Million | 6.64 Million | 12.14 Million |
| Inventory | -5.99 Million | -18.61 Million | 3.18 Million | -528 Thousand | -1.42 Million | 3.25 Million |
| Other working capital | -1.97 Million | 22.09 Million | -14.61 Million | -733 Thousand | -3.88 Million | -422 Thousand |
| Cash at beginning of period | 30.18 Million | 99.21 Million | 86.83 Million | 64.52 Million | 42.77 Million | 17.1 Million |
| Cash at end of period | 36.96 Million | 31.83 Million | 99.21 Million | 86.83 Million | 64.52 Million | 42.77 Million |
| Capital Expenditure | -7.36 Million | -11.52 Million | -7.37 Million | -20.67 Million | -8.34 Million | -6.06 Million |
| Effect of forex changes on cash | 629 Thousand | 521 Thousand | -228 Thousand | 589 Thousand | -104 Thousand | -160 Thousand |
| Net cash flow / Change in cash | 6.77 Million | -67.37 Million | 12.37 Million | 22.31 Million | 21.74 Million | 25.67 Million |
| Free Cash Flow | 7.98 Million | -25.05 Million | 15.62 Million | 51.12 Million | 32.37 Million | 39.12 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -14.95 Million | -23.99 Million | -4.57 Million | -6.09 Million | -96.73 Million | -8.79 Million |
| Depreciation & Amortization | 12.27 Million | 13.09 Million | 11.78 Million | 12.46 Million | 57.36 Million | 13.82 Million |
| Deferred income taxes | -511 Thousand | -8.17 Million | 81 Thousand | 1.16 Million | -2.37 Million | 865 Thousand |
| Stock-based compensation | 2.06 Million | 3.67 Million | 2.59 Million | 1.77 Million | 2.72 Million | 1.83 Million |
| Change in working capital | 9.21 Million | 5.54 Million | -14.75 Million | 1.97 Million | -3.18 Million | -16.21 Million |
| Other non-cash items | 3.4 Million | 49.26 Million | 37.2 Million | -908 Thousand | 57.55 Million | 164 Thousand |
| Investing Cash Flow | -64 Thousand | -77 Thousand | -1 Million | -591 Thousand | 15.8 Million | -2.03 Million |
| Investments in PPE | 645 Thousand | -77 Thousand | -1 Million | -369 Thousand | -7.36 Million | -2.03 Million |
| Acquisitions | - | - | - | -222 Thousand | 34.67 Million | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -709 Thousand | - | -709 Thousand | -222 Thousand | -11.5 Million | - |
| Financing Cash Flow | -818 Thousand | -7.84 Million | -3.06 Million | -14 Thousand | -26.65 Million | 8.22 Million |
| Debt repayment | -11.31 Million | -8.26 Million | -3.05 Million | -87.26 Million | -26.92 Million | -7 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 553 Thousand | 609 Thousand | 177 Thousand | 158 Thousand | 778 Thousand | 397 Thousand |
| Other Financing Activities | 9.94 Million | -190 Thousand | -183 Thousand | -172 Thousand | -506 Thousand | 14.83 Million |
| Accounts receivables | 17.05 Million | -19.97 Million | -1.95 Million | -9.19 Million | 10.05 Million | 7.91 Million |
| Accounts payables | -21.32 Million | 29.88 Million | -7.33 Million | 5.79 Million | -5.27 Million | -25.83 Million |
| Inventory | -2.51 Million | -4.28 Million | -4.07 Million | 8.13 Million | -5.99 Million | -1.04 Million |
| Other working capital | 1.47 Million | -77 Thousand | -1.39 Million | -2.75 Million | -1.97 Million | 2.75 Million |
| Cash at beginning of period | 31.99 Million | 25.17 Million | 36.96 Million | 26.82 Million | 30.18 Million | 29.38 Million |
| Cash at end of period | 43.07 Million | 31.99 Million | 25.17 Million | 36.96 Million | 36.96 Million | 26.82 Million |
| Capital Expenditure | 645 Thousand | -77 Thousand | -1 Million | -369 Thousand | -7.36 Million | -2.03 Million |
| Effect of forex changes on cash | 466 Thousand | -419 Thousand | -544 Thousand | 368 Thousand | 629 Thousand | -440 Thousand |
| Net cash flow / Change in cash | 11.08 Million | 6.82 Million | -11.79 Million | 10.13 Million | 6.77 Million | -2.56 Million |
| Free Cash Flow | 12.14 Million | 15.08 Million | -8.18 Million | 10 Million | 7.98 Million | -10.35 Million |
EPRT
ATDS
UBS
KR
3592
TRIBO-B